.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 5,047,407

« Back to Dashboard

Claims for Patent: 5,047,407

Title: 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
Abstract:Methods and compositions for preventing or treating human immunodeficiency virus (HIV) infections characterized by 2-substituted-5-substituted-1,3-oxathiolanes.
Inventor(s): Belleau; Bernard (Westmount, CA), Nguyen-Ba; Nghe (Brossard, CA)
Assignee: IAF BioChem International, Inc. (Montreal, CA)
Application Number:07/308,101
Patent Claims: 1. A 1,3-oxathiolane of formula (A), the geometric and optical isomers thereof, and mixtures of those isomers: ##STR23## wherein: Z is selected from the group consisting of sulfur, sulfoxide, and sulfone;

R.sub.1 is selected from the group consisting of hydrogen and an acyl group having 1 to 16 carbon atoms;

R.sub.2 is a heterocyclic radical selected from the group consisting of: ##STR24## R.sub.3 and R.sub.4 are independently selected from the group consisting of hydrogen and C.sub.1-6 alkyl groups;

R.sub.5 is selected from the group of hydrogen, C.sub.1-6 alkyl, bromine, chlorine, fluorine, and iodine; and

X and Y are independently selected from the group consisting of bromine, chlorine, fluorine, iodine, amino and hydroxyl groups.

2. A compound according to claim 1 wherein R.sub.1 is hydrogen and R.sub.2 is cytosin-1'-yl.

3. A compound according to claim 1 wherein R.sub.1 is hydrogen and R.sub.2 is thymin-1'-yl.

4. A compound according to claim 1 wherein R.sub.1 is hydrogen and R.sub.2 is uracil-1'-yl.

5. The compound according to claim 1 where R.sub.1 is selected from the group consisting of acetyl, hexanoyl and benzoyl which may be substituted by a group selected from the group consisting of OH, OCH.sub.3, NO.sub.2, CF.sub.3 and NH.sub.2.

6. A method for treating human immunodeficiency virus infections in animals and humans, characterized by administering an antiviral effective amount of a compound of a 1,3-oxathiolane of Formula (A), the geometric and optical isomers thereof, and mixtures of those isomers: ##STR25## wherein: Z is selected from the group consisting of sulfur, sulfoxide and sulfone;

R.sub.1 is selected from the group consisting of hydrogen and an acyl group having 1 to 16 carbon atoms;

R.sub.2 is a heterocyclic radical selected from the group consisting of: ##STR26## R.sub.3 and R.sub.4 are independently selected from the group consisting of hydrogen and C.sub.1-6 alkyl groups;

R.sub.5 is selected from the group of hydrogen, C.sub.1-6 alkyl, bromine, chlorine, fluorine, and iodine; and

X and Y are independently selected from the group consisting of bromine, chlorine, fluorine, iodine, amino and hydroxyl groups.

7. A pharmaceutical composition for use in treating HIV infections in animals and humans, characterized by an antiviral effective amount of a compound selected from the group consisting of a 1,3-oxathiolane of formula (A), the geometric and optical isomers thereof, and mixtures of those isomers: ##STR27## wherein: Z is selected from the group consisting of sulfur, sulfoxide and sulfone;

R.sub.1 is selected from the group consisting of hydrogen and an acyl group having 1 to 16 carbon atoms;

R.sub.2 is a heterocyclic radical selected from the group consisting of: ##STR28## R.sub.3 and R.sub.4 are independently selected from the group consisting of hydrogen and C.sub.1-6 alkyl groups;

R.sub.5 is selected from the group of hydrogen, C.sub.1-6 alkyl, bromine, chlorine, fluorine, and iodine; and

X and Y are independently selected from the group consisting of bromine, chlorine, fluorine, iodine, amino and hydroxyl groups.

8. A compound of Formula IX the geometric and optical isomers thereof, and mixtures of those isomers. ##STR29##

9. A compound of Formula X the geometric and optical isomers thereof, and mixtures of those isomers. ##STR30##

10. A compound of Formula XI the geometric and optical isomers thereof, and mixtures of those isomers. ##STR31##

11. A compound of Formula XII the geometric and optical isomers thereof, and mixtures of those isomers. ##STR32##

12. The compound according to claim 1 wherein R.sub.1 is an aroyl.

13. The compound according to claim 1 wherein R.sub.1 is a benzoyl substituted in any position by at least one bromine, chlorine, fluorine, iodine, C.sub.1-6 alkyl, C.sub.1-6 alkoxy, nitro or trifluoromethyl group.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc